BookRags.com Literature Guides Literature
Guides
Criticism & Essays Criticism &
Essays
Questions & Answers Questions &
Answers
Lesson Plans Lesson
Plans
My Bibliography Periodic Table U.S. Presidents Shakespeare Sonnet Shake-Up
Research Anything:        
History | Encyclopedias | Films | News | Create a Bibliography | More... Login | Register | Help


Search "Murad, Ferid"

Navigation

Murad, Ferid

Print-Friendly  Order the PDF version  Order the RTF version
About 1 pages (394 words)
Ferid Murad Summary

(born Sept. 14, 1936, Whiting, Ind., U.S.) American pharmacologist, who, along with Robert F. Furchgott and Louis J. Ignarro, was co-awarded the 1998 Nobel Prize in Physiology or Medicine for the discovery that nitric oxide (NO) acts as a signaling molecule in the cardiovascular system. Their combined work uncovered an entirely new mechanism for how blood vessels in the body relax and widen.

Murad received his M.D. and Ph.D. from Western Reserve University (later Case Western Reserve University) in Cleveland, Ohio, in 1965. In addition to his clinical practice, Murad taught pharmacology at the University of Virginia School of Medicine, Charlottesville (1975–81), at Stanford University (1981–89), and then at Northwestern University (1988). While at Stanford he ventured into the private sector as a vice president of Abbott Laboratories (1988–92) and then became president of the Molecular Geriatrics Corporation (1993–95). He began teaching at the medical school of the University of Texas, Houston, in 1997.

In 1977 Murad showed that nitroglycerin and several related heart drugs induce the formation of nitric oxide and that the colourless, odourless gas acts to increase the diameter of blood vessels in the body. Furchgott and Ignarro built on this work. About 1980 Furchgott demonstrated that cells in the endothelium, or inner lining, of blood vessels produce an unknown signaling molecule, which he named endothelium-derived relaxing factor (EDRF). This molecule signals smooth muscle cells in blood vessel walls to relax, dilating the vessels. Ignarro's research, conducted in 1986 and done independently of Furchgott's work, identified EDRF as nitric oxide. These discoveries led to the development of the anti-impotence drug sildenafil citrate (Viagra) and had the potential to unlock new approaches for understanding and treating other diseases.

The Nobel Assembly of the Karolinska Institute in Stockholm, which presented the prize, said that the identification of a biological role for nitric oxide was surprising for several reasons. Nitric oxide was known mainly as a harmful air pollutant, released into the atmosphere from automobile engines and other combustion sources. In addition, it was a simple molecule, very different from the complex neurotransmitters and other signaling molecules that regulate many biological events. No other gas is known to act as a signaling molecule in the body.

Murad was also the recipient of the Albert Lasker Basic Medical Research Award in 1996 for his discovery. Murad and Ignarro collaborated on Nitric Oxide: Biochemistry, Molecular Biology, and Therapeutic Implications (1995).

This is the complete article, containing 394 words (approx. 1 page at 300 words per page).

View More Summaries on Ferid Murad
More Information
  • View Murad, Ferid Study Pack
  • Search Results for "Murad, Ferid"
  • Add This to Your Bibliography
  • More Products on This Subject
    Ferid Murad
    Together with fellow American pharmacologists Robert Furchgott and Louis Ignarro, Murad received th... more

    Ferid Murad
    Ferid Murad shared the 1998 Nobel Prize in physiology or medicine with Robert Furchgott and Louis I... more


     
    Copyrights
    Murad, Ferid from Encyclopedia Brittanica. ©2009 Encyclopedia Brittanica. All rights reserved.

    Join BookRagslearn moreJoin BookRags




    About BookRags | Customer Service | Report an Error | Terms of Use | Privacy Policy